Suwilanji Silwamba

A pilot study on use of live attenuated rotavirus vaccine (Rotarix™) as an infection challenge model.

N. Grassly, R. Chilengi, S. Bosomprah, 2020, Vaccine.

Field evaluation of a novel, rapid diagnostic assay, and molecular epidemiology of enterotoxigenic E. coli among Zambian children presenting with diarrhea

G. Dougan, R. Chilengi, S. Chakraborty, 2022, medRxiv.

Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing

R. Chilengi, M. Simuyandi, N. Laban, 2023, Vaccines.

Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0–36 Months in Peri-Urban Areas of Lusaka

R. Chilengi, S. Bosomprah, K. Mwape, 2023, Microorganisms.